Business & Finance
Biotech company announces contracts, adds to biodefense and vaccine development activities
Published in Vaccine Weekly, December 14th, 2005
The new contracts add to CBI's expanding contract base in biodefense and vaccine development support activities. Coming on the heels of a record revenue quarter for CBI and one in which $1.5 million in new contract work was announced recently, these new contracts are more evidence of CBI's growing market share in these two key growth areas. Work on both contracts has already begun and will continue throughout 2006 and into 2007. Revenues from these new contracts are expected to be realized in the fourth...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-12-14)
More Articles from Vaccine Weekly
- E. Coli Vaccine
E. coli O157:H7 bacterial ghosts protect against lethal challenge - Influenza Vaccine
Sequencing of influenza reveals dynamic nature of viral genome evolution - Meningococcal Vaccine
LPS-based glycoconjugates prevent invasive meningococcal disease - Tobacco Use
Safe therapeutic vaccine for nicotine dependence has been developed - Tuberculosis Vaccine
Boosting with M. tuberculosis major secretory protein enhances BCG vaccine protection - Apoptosis
2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) induced apoptosis in pancreatic cancer - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
